Category: Cardiac ImplantsSyndicate content

Boston Scientific touts 1st Watchman implantations

March 25, 2015 by Brad Perriello

Boston Scientific touts the 1st commercial implantations of its Watchman anti-stroke heart implant.

Boston Scientific touts 1st Watchman implantations

UPDATE: Boston Scientific jumps on Watchman approval

March 16, 2015 by Brad Perriello

Shares of Boston Scientific jump today after the FDA approves its Watchman anti-stroke device.

UPDATE: Boston Scientific jumps on Watchman approval

Investors sent shares of Boston Scientific (NYSE:BSX) up nearly 4% today after the medical device company said the FDA approved its long-delayed Watchman anti-stroke device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ACC 2015: St. Jude Medical's CardioMEMS HF lowers mortality, hospitalizations

March 16, 2015 by Brad Perriello

A retrospective analysis of St. Jude Medical's CardioMEMS HF implantable heart monitor shows it helps reduce death and hospitalization rates for heart failure patients.

ACC 2015: St. Jude Medical's CardioMEMS HF lowers mortality, hospitalizations

FDA approves Boston Scientific's Watchman anti-stroke device

March 16, 2015 by Brad Perriello

Six years after an FDA panel 1st recommended approval, the safety watchdog grants pre-market approval to Boston Scientific's Watchman anti-stroke cardiac implant.

FDA approves Boston Scientific's Watchman anti-stroke device

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic touts real-world study of Reveal Linq heart monitor

February 11, 2015 by Brad Perriello

Medtronic touts a real-world study of its Reveal Linq insertable cardiac monitor for detecting atrial fibrillation and says a separate analysis shows that long-term implanted cardiac monitoring is cost-effective.

Medtronic touts real-world study of Reveal Linq monitor

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Positive data for Neovasc study of stent-like angina device

February 9, 2015 by Mark Hollmer

Neovasc reports positive data from a study of its stent-like device to treat refractory angina were published in the New England Journal of Medicine.

Positive data for Neovasc study of stent-like angina device

Neovasc (NYSE:NVC) said its device to treat refractory angina – implanted much like a coronary stent – met the endpoints in a clinical trial involving 104 patients.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

SynCardia wins FDA nod for destination therapy trial

January 7, 2015 by Mark Hollmer

SynCardia gains the FDA's O.K. to test its artificial heart as a permanent implant in 19 patients.

SynCardia wins FDA nod for destination therapy trial

SynCardia plans to test its artificial heart as a permanent implant rather than a placeholder for donor transplants in 19 patients.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.